These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 20658441)

  • 1. Substance P is associated with the development of obesity, chronic inflammation and type 2 diabetes mellitus.
    Fu J; Liu B; Liu P; Liu L; Li G; Wu B; Liu X
    Exp Clin Endocrinol Diabetes; 2011 Mar; 119(3):177-81. PubMed ID: 20658441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-grade systemic inflammation and the risk of type 2 diabetes in obese children and adolescents.
    Syrenicz A; Garanty-Bogacka B; Syrenicz M; Gebala A; Walczak M
    Neuro Endocrinol Lett; 2006 Aug; 27(4):453-8. PubMed ID: 16892000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes, and NASH.
    Anty R; Bekri S; Luciani N; Saint-Paul MC; Dahman M; Iannelli A; Amor IB; Staccini-Myx A; Huet PM; Gugenheim J; Sadoul JL; Le Marchand-Brustel Y; Tran A; Gual P
    Am J Gastroenterol; 2006 Aug; 101(8):1824-33. PubMed ID: 16790033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients.
    Kopp HP; Kopp CW; Festa A; Krzyzanowska K; Kriwanek S; Minar E; Roka R; Schernthaner G
    Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1042-7. PubMed ID: 12714437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between serum values of C-reactive protein and cytokine production in whole blood of patients with type 2 diabetes.
    Castoldi G; Galimberti S; Riva C; Papagna R; Querci F; Casati M; Zerbini G; Caccianiga G; Ferrarese C; Baldoni M; Valsecchi MG; Stella A
    Clin Sci (Lond); 2007 Jul; 113(2):103-8. PubMed ID: 17362204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An exercise intervention without weight loss decreases circulating interleukin-6 in lean and obese men with and without type 2 diabetes mellitus.
    Dekker MJ; Lee S; Hudson R; Kilpatrick K; Graham TE; Ross R; Robinson LE
    Metabolism; 2007 Mar; 56(3):332-8. PubMed ID: 17292721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease.
    Klein S; Fontana L; Young VL; Coggan AR; Kilo C; Patterson BW; Mohammed BS
    N Engl J Med; 2004 Jun; 350(25):2549-57. PubMed ID: 15201411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose metabolism.
    Blüher M; Fasshauer M; Tönjes A; Kratzsch J; Schön MR; Paschke R
    Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):534-7. PubMed ID: 16235156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women.
    Piché ME; Lemieux S; Weisnagel SJ; Corneau L; Nadeau A; Bergeron J
    Am J Cardiol; 2005 Jul; 96(1):92-7. PubMed ID: 15979442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meal testing and postprandial state of type 2 diabetic patients with metabolic syndrome.
    Brădescu OM; Georgescu M; Ifrim S; Ioacără S; Ionescu-Tîrgovişte C
    Rom J Intern Med; 2005; 43(1-2):97-113. PubMed ID: 16739870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of C-reactive protein expression in type 2 diabetes mellitus complicated with vascular lesions and its clinical significance].
    Ran RZ; Tu YY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jul; 26(7):691-3. PubMed ID: 20862801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistin - concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease.
    Stejskal D; Adamovská S; Bartek J; Juráková R; Prosková J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2003 Nov; 147(1):63-9. PubMed ID: 15034607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus.
    Kadoglou NP; Iliadis F; Angelopoulou N; Perrea D; Ampatzidis G; Liapis CD; Alevizos M
    Eur J Cardiovasc Prev Rehabil; 2007 Dec; 14(6):837-43. PubMed ID: 18043308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 (IL-6) -572C-->G promoter polymorphism is associated with type 2 diabetes risk in Koreans.
    Koh SJ; Jang Y; Hyun YJ; Park JY; Song YD; Shin KK; Chae JS; Kim BK; Ordovas JM; Lee JH
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):238-44. PubMed ID: 18573122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
    Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoprotegerin in relation to type 2 diabetes mellitus and the metabolic syndrome in postmenopausal women.
    Nabipour I; Kalantarhormozi M; Larijani B; Assadi M; Sanjdideh Z
    Metabolism; 2010 May; 59(5):742-7. PubMed ID: 19922962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome.
    Santos AC; Lopes C; Guimarães JT; Barros H
    Int J Obes (Lond); 2005 Dec; 29(12):1452-6. PubMed ID: 16077717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index.
    Ruge T; Lockton JA; Renstrom F; Lystig T; Sukonina V; Svensson MK; Eriksson JW
    Metabolism; 2009 Jun; 58(6):860-6. PubMed ID: 19375766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of increased ambulatory activity on markers of chronic low-grade inflammation: evidence from the PREPARE programme randomized controlled trial.
    Yates T; Davies MJ; Gorely T; Talbot D; Bull F; Sattar N; Khunti K
    Diabet Med; 2010 Nov; 27(11):1256-63. PubMed ID: 20950383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postprandial variations of plasma inflammatory markers in abdominally obese men.
    Blackburn P; Després JP; Lamarche B; Tremblay A; Bergeron J; Lemieux I; Couillard C
    Obesity (Silver Spring); 2006 Oct; 14(10):1747-54. PubMed ID: 17062804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.